SAN DIEGO--(BUSINESS WIRE)--May 25, 2006--MultiCell Technologies, Inc. (OTCBB: MCET - News), a developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, announced that its annual stockholder meeting was held Tuesday, May 23, in San Diego, CA. Two proposals were reviewed and passed.
